non hodgkin lymphoma
Showing NaN - NaN of 10
Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)
Active, not recruiting
- Non Hodgkin Lymphoma
- Magrolimab
- +3 more
-
Birmingham, Alabama
- +19 more
Dec 8, 2022
Hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in United States (AB-205, Placebo)
Recruiting
- Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- AB-205
- Placebo
-
Duarte, California
- +20 more
Aug 2, 2022
Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in United States (TGR-1202, TGR-1202 + Ublituximab)
Terminated
- Chronic Lymphocytic Leukemia
- Non Hodgkin Lymphoma
- TGR-1202
- TGR-1202 + Ublituximab
-
Huntsville, Alabama
- +16 more
Jul 20, 2022
Follicular Lymphoma (FL), Non Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Zandelisib (ME-401))
Recruiting
- Follicular Lymphoma (FL)
- +2 more
- Zandelisib (ME-401)
-
Tucson, Arizona
- +115 more
Mar 8, 2022
Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Denver, Nashville, Houston (TC-110 T
Recruiting
- Non Hodgkin Lymphoma
- +5 more
- TC-110 T Cells
- +2 more
-
Denver, Colorado
- +2 more
Jun 25, 2020